Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Sign up for the iNFOnews newsletter today!
Selecting your primary region ensures you get the stories that matter to you first.
NEW YORK, N.Y. – A federal panel says older Americans should start getting a new vaccine against bacteria that cause pneumonia.
The Advisory Committee on Immunization Practices voted Wednesday to recommend a dose of the expensive new shot for people 65 and older. The panel said older adults should still get an older pneumococcal vaccine, too.
The newer vaccine — Pfizer’s Prevnar-13 — was licensed in 2011 and costs about $135 per dose. It already is recommended for infants and people with certain medical conditions.
One dose of an older vaccine — which targets a different lineup of bacteria — remained the standard for older adults. A Dutch study this year found Prevnar-13 prevented more pneumonia in the elderly.
Officials believe the new shot could prevent 5,000 illnesses a year.
___
Online:
Panel: http://www.cdc.gov/vaccines/acip
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.